Skip to main content
. 2022 Feb 18;7(2):260–270. doi: 10.1002/epi4.12583

FIGURE 1.

FIGURE 1

Percent of respondents from various ILAE regions who reported problems with generic antiseizure medications (ASM) products from the list of WHO essential medications